Drug Testing Locations - Kansas, OK

Drug Testing in Kansas, OK

Kansas, Oklahoma Statistics

Kansas, Delaware County has seen a 15% increase in opioid-related hospitalizations over the past three years.

Methamphetamine-related arrests in Kansas, Delaware County have doubled since 2018.

In 2021, Kansas, Delaware County reported 75 cases of substance abuse among minors.

Kansas in Delaware County's drug overdose deaths rose by 10% from 2019 to 2022.

The rate of drug treatment admissions in Kansas, Delaware County increased by 20% in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Kansas, OK & Drug Testing Policies

Employers in Kansas, OK, recognize the significance of maintaining a drug-free workplace and often implement drug testing policies as part of their employment practices. These policies typically include pre-employment screening and random testing to deter substance abuse. The Occupational Safety and Health Administration provides guidelines to help employers develop comprehensive drug testing programs that comply with federal regulations.

Additionally, companies may partner with local health agencies to offer employee assistance programs that provide support and resources for workers struggling with addiction. By maintaining strict yet supportive drug policies, employers aim to ensure a safe and productive work environment in Kansas, OK.

Government Efforts with Drug Problems in Kansas, OK

The government of Kansas, OK, and Delaware County is actively working to mitigate the impact of drug abuse through various initiatives. Collaborative efforts with state agencies like the Oklahoma Department of Mental Health and Substance Abuse Services focus on expanding access to treatment and recovery programs. Additionally, local law enforcement agencies partner with community organizations to promote awareness and education.

Federal resources are also being leveraged, with agencies like the Drug Enforcement Administration supporting local efforts through grants and training. These integrated approaches aim to reduce drug demand and supply, enhance community resilience, and provide support for those affected by substance use disorders in Kansas, OK.

Local Drug Busts & News in Kansas, OK

Kansas, OK has experienced several drug-related events in recent years, highlighting the ongoing challenges in the area. Law enforcement agencies have conducted significant drug busts in Delaware County, leading to the seizure of large quantities of illegal substances. These operations often involve collaborative efforts with neighboring jurisdictions and federal authorities to dismantle drug trafficking networks.

Community engagement events, such as drug take-back days and public forums, are regularly organized to encourage residents to dispose of unused medications safely and to raise awareness about the risks of drug abuse. Such initiatives aim to foster a sense of community responsibility and resilience against the drug crisis affecting Kansas, OK.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Kansas, OK. Trusted by employers nationwide for accurate results and exceptional service.

Oklahoma DOT/Non DOT Physicals

Oklahoma Vision Tests

Oklahoma Audiograms

Oklahoma Respirator Fit Tests

Oklahoma Lift Tests

Oklahoma Background Checks

Clinical Testing Services

TB Testing in OK

Diabetes Testing in OK

Infectious Disease Testing in OK

Sickle Cell Anemia Testing in OK

Women/Men's Health Testing in OK

Resources & Citations

Oklahoma Department of Mental Health and Substance Abuse Services

Oklahoma State Department of Health

Treatment Referral Routing Service

Substance Abuse and Mental Health Services Administration

Narconon Arrowhead

211 Oklahoma

Narcotics Anonymous Oklahoma

Oklahoma Department of Human Services

Drug Testing Near Kansas, OK

Kenwood, OK

West Siloam Springs, OK

Teresita, OK

Tagg Flats, OK

Bull Hollow, OK

Chewey, OK

Colcord, OK

Leach, OK

Rocky Ford, OK

Cloud Creek, OK

Flint Creek, OK

Oaks, OK

Twin Oaks, OK

Frequently Asked Questions

Customer Reviews